Monoclonal anti-CD20 antibodies (Mabthera) in the treatment of auto-immune hemolytic anemia - M. Pavkovic; D.G. Efremov; B. Georgievski; S. Stankovic; S. Genadieva Stavric; I. Panovska; L. Cevreska (European Hematology Association, 2003)
Keywords: anti-CD20 antibody; Mabthera (Rituximab); hemolytic anemia